In October of 2006, Dr. Guerra was appointed Director of Sales and Marketing for NeoStem. As a pioneer in umbilical cord and placental stem cell science since the mid 1990s, Dr. Guerra brings extensive experience in healthcare marketing. He will be responsible for developing NeoStem�s alliances with hospitals, physicians and health and wellness clinics nationwide for the establishment of adult stem cell collection centers.
Previously Dr. Guerra was Senior Vice President of Marketing and New Program Development at Anthrogenesis Corporation until 2002, when the company, a private business focused on cord blood banking and placental stem cell therapeutics, was acquired by Celgene Corporation (Nasdaq:CELG). As an experienced healthcare marketing consultant for many Fortune 500 companies such as Gerber, Ross Products and Mead Johnson, he brought his expertise in online and offline marketing to Anthrogenesis and developed a robust and successful advertising and public relations campaign in addition to a state-of-the-art interactive website.
Immediately following the acquisition by Celgene, Dr. Guerra co-founded Bancovida, a company that developed umbilical cord and placental stem cell donor programs in Puerto Rico. Within four months he had enrolled six major hospitals and over 120 physicians, making Bancovida the largest umbilical cord and placental stem cell donor program in the world, collecting over 6,000 units in a year and a half. As Chief Operating Officer of Bancovida, Dr. Guerra was in charge of all aspects of this new company including hospital recruitment, human resources, professional education, transport logistics, medical records and online database development.
Dr. Guerra is trained in both Internal Medicine and Pediatrics. Immediately after graduation from residency, he served as Director of Ambulatory Pediatrics and was asked to be on the board of Atlantic Health Care MSO Project. He is the medical director of College Plaza Pediatrics and is a diplomate of the American Board of Pediatrics. He is well known for his newborn visual stimulation designs which he developed in 1994 and has received many awards including Best Doctors of America in 2005. His clinical interests are in high risk pediatrics and growth and development. Dr. Guerra is presently collaborating with the Columbia Presbyterian Pediatric Transplant team in hopes of utilizing umbilical cord stem cells for the treatment and cure of Sickle Cell Anemia for one of his patients.
He is an associate member of the American Society of Blood and Marrow Transplant. He has lectured to many medical professional groups both in the United States and internationally regarding the science of umbilical cord and placental stem cell technologies. |